Cargando…

Serotonin-Related Functional Genetic Variants Affect the Occurrence of Psychiatric and Motor Adverse Events of Dopaminergic Treatment in Parkinson’s Disease: A Retrospective Cohort Study

The serotonergic system is important in Parkinson’s disease (PD) pathogenesis as it can take over dopamine production after a large portion of dopaminergic neurons is lost through neurodegeneration. The aim of this study was to evaluate the effect of genetic variability of serotonergic genes on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redenšek, Sara, Blagus, Tanja, Trošt, Maja, Dolžan, Vita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875505/ https://www.ncbi.nlm.nih.gov/pubmed/35207756 http://dx.doi.org/10.3390/jpm12020266

Ejemplares similares

Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson’s Disease and Dopaminergic Treatment Adverse Events
por: Redenšek, Sara, et al.
Publicado: (2022)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2020)

Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
por: Redenšek, Sara, et al.
Publicado: (2017)

Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson’s Disease
por: Levstek, Tina, et al.
Publicado: (2021)

From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms
por: Redenšek, Sara, et al.
Publicado: (2018)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
por: Pjevac, Milica, et al.
Publicado: (2023)

Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson’s Disease
por: Petrič, Boštjan, et al.
Publicado: (2023)

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies
por: Tsermpini, Evangelia Eirini, et al.
Publicado: (2022)

Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype
por: Atanasovska Velkovska, Makedonka, et al.
Publicado: (2021)

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
por: Redenšek Trampuž, Sara, et al.
Publicado: (2023)

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
por: Terzić, Tea, et al.
Publicado: (2015)

Dopaminergic modulation of motor network dynamics in Parkinson’s disease
por: Michely, Jochen, et al.
Publicado: (2015)

Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
por: Tsermpini, Evangelia Eirini, et al.
Publicado: (2022)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

Nanoscale Bilirubin Analysis in Translational Research and Precision Medicine by the Recombinant Protein HUG
por: Sist, Paola, et al.
Publicado: (2023)

Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
por: Trinh, Ilene, et al.
Publicado: (2023)

Inflammation and Oxidative Stress Gene Variability in Retinal Detachment Patients with and without Proliferative Vitreoretinopathy
por: Lumi, Xhevat, et al.
Publicado: (2023)

Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences
por: Buhmann, Carsten, et al.
Publicado: (2017)

Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, M. A., et al.
Publicado: (2023)

A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons
por: Espeso-Gil, Sergio, et al.
Publicado: (2020)

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
por: Bittner, Nadine, et al.
Publicado: (2023)

Chloroquine: Psychiatric adverse events: case report
Publicado: (2020)

Associations of the serotonin transporter gene polymorphism, 5-HTTLPR, and adverse life events with late life depression in the elderly Lithuanian population
por: Simonyte, Sandrita, et al.
Publicado: (2023)

Associations of NLRP3 and CARD8 Gene Polymorphisms with Alcohol Dependence and Commonly Related Psychiatric Disorders: a Preliminary Study
por: Ilješ, Anja Plemenitaš, et al.
Publicado: (2021)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

The dopaminergic system supports flexible and rewarding dyadic motor interactive behaviour in Parkinson’s Disease
por: Era, Vanessa, et al.
Publicado: (2022)

Dopaminergic modulation of performance monitoring in Parkinson’s disease: An event-related potential study
por: Seer, Caroline, et al.
Publicado: (2017)

Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
por: Petric, Rok, et al.
Publicado: (2016)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Understanding the role of serotonin in psychiatric diseases
por: Marazziti, Donatella
Publicado: (2017)

Dopaminergic nuclei in the chick midbrain express serotonin receptor subfamily genes
por: Fujita, Toshiyuki, et al.
Publicado: (2022)

Differences in Dopaminergic Modulation to Motor Cortical Plasticity between Parkinson's Disease and Multiple System Atrophy
por: Kawashima, Shoji, et al.
Publicado: (2013)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease
por: Greenbaum, Lior, et al.
Publicado: (2013)

Endocannabinoid Modulation of Dopaminergic Motor Circuits
por: Morera-Herreras, Teresa, et al.
Publicado: (2012)

Risk factors associated with the occurrence of adverse events in plateletpheresis donation
por: Barbosa, Maria Helena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3hplf6ukqvkb7tcaj674it5rkm